James P. Quinlan - 13 Aug 2025 Form 4 Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Chief Financial Officer
Signature
/s/ James P. Quinlan
Issuer symbol
MDCX
Transactions as of
13 Aug 2025
Net transactions value
+$156,250
Form type
4
Filing time
14 Aug 2025, 16:01:38 UTC
Previous filing
24 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Quinlan James P. Chief Financial Officer 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W.CONSHOHOCKEN /s/ James P. Quinlan 14 Aug 2025 0002047493

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDCX Common Shares, no par value ("Common Shares") Options Exercise $101,250 +125,000 +97% $0.8100 254,147 13 Aug 2025 Direct F1
transaction MDCX Common Shares Options Exercise $55,000 +20,000 +7.9% $2.75 274,147 13 Aug 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDCX Stock Option (right to buy) Options Exercise $0 -125,000 -100% $0.000000 0 13 Aug 2025 Common Shares 125,000 $0.8100 Direct F1, F3
transaction MDCX Stock Option (right to buy) Options Exercise $0 -20,000 -100% $0.000000 0 13 Aug 2025 Common Shares 20,000 $2.75 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
F2 Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
F3 The option was vested and was exercisable as of the Transaction Date.